Use of compounds extracted from Momordica charantia L. in the manufacture of medicaments for prevention and treatment of diabetes and obesity

Details for Australian Patent Application No. 2009212026 (hide)

Owner The Garvan Institute of Medical Research, Australia Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Inventors Li, Xiqiang; Ke, Changqiang; Chen, Tong; Ye, Yang; Cooney, Gregory J.; Ye, Jiming; Kraegen, Edward W.; Tan, Minjia; James, David E.

Agent Freehills

Pub. Number AU-B-2009212026

PCT Pub. Number WO2009/097735

Priority 200810033348.5 31.01.08 CN

Filing date 14 January 2009

Wipo publication date 13 August 2009

Acceptance publication date 23 August 2012

International Classifications

A61K 31/704

A61K 31/575 - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 3/04 Drugs for disorders of the metabolism

A61P 3/10 Drugs for disorders of the metabolism

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/097735 Priority application(s): WO2009/097735

23 August 2012 Application Accepted

  Published as AU-B-2009212026

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212065-Compositions and methods for alleviating depression or improving cognition

2009211973-Actuator